tiprankstipranks
Infant Bacterial Therapeutics AB (DE:9IB)
FRANKFURT:9IB
Germany Market

Infant Bacterial Therapeutics AB (9IB) Technical Analysis

4 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Infant Bacterial Therapeutics AB’s (9IB) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Infant Bacterial Therapeutics AB is a Sell.
Infant Bacterial Therapeutics AB’s (9IB) 20-Day exponential moving average is 4.50, while Infant Bacterial Therapeutics AB’s (9IB) share price is €4.48, making it a Sell.
Infant Bacterial Therapeutics AB’s (9IB) 50-Day exponential moving average is 4.59, while Infant Bacterial Therapeutics AB’s (9IB) share price is €4.48, making it a Sell.

Infant Bacterial Therapeutics AB (9IB) Pivot Points

Apr 09, 2026, 12:45 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.32
4.34
4.40
4.43
4.49
4.51
4.57
Fibonacci
4.34
4.38
4.40
4.43
4.46
4.48
4.51
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Infant Bacterial Therapeutics AB (9IB) Moving Averages

Apr 09, 2026, 12:45 PM
Period
Simple
Exponential
MA5
4.43Buy
4.44Sell
MA10
4.44Buy
4.45Sell
MA20
4.48Sell
4.50Sell
MA50
4.65Sell
4.59Sell
MA100
4.55Sell
4.70Sell
MA200
4.93Sell
4.89Sell
Infant Bacterial Therapeutics AB’s (9IB) 10-Day exponential moving average is 4.45, while Infant Bacterial Therapeutics AB’s (9IB) share price is €4.48, making it a Sell.
Infant Bacterial Therapeutics AB’s (9IB) 100-Day exponential moving average is 4.70, while Infant Bacterial Therapeutics AB’s (9IB) share price is €4.48, making it a Sell.
Infant Bacterial Therapeutics AB’s (9IB) stock price is €4.48 and Infant Bacterial Therapeutics AB’s (9IB) 50-day simple moving average is 4.65, creating a Sell signal.
Infant Bacterial Therapeutics AB’s (9IB) stock price is €4.48 and Infant Bacterial Therapeutics AB’s (9IB) 100-day simple moving average is 4.55, creating a Sell signal.
Infant Bacterial Therapeutics AB’s (9IB) stock price is €4.48 and Infant Bacterial Therapeutics AB’s (9IB) 200-day simple moving average is 4.93, creating a Sell signal.

Infant Bacterial Therapeutics AB (9IB) Technical Indicators

Apr 09, 2026, 12:45 PM
Name
Value
Implied Action
RSI (14)
46.06
Neutral
STOCH (9,6)
45.74
Neutral
STOCHRSI (14)
42.85
Neutral
MACD (12,26)
-0.06
Sell
ADX (14)
19.37
Buy
Williams %R
-51.16
Buy
CCI (14)
-44.73
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
39.91
Neutral
ROC
-2.20
Sell
Infant Bacterial Therapeutics AB’s (9IB) Relative Strength Index (RSI) is 46.06, creating a Neutral signal.
Infant Bacterial Therapeutics AB’s (9IB) Trend Strength Indicator (ADX) is 19.37, creating a Buy signal.
Infant Bacterial Therapeutics AB’s (9IB) Commodity Channel Index (CCI) is -44.73, creating a Neutral signal.
Infant Bacterial Therapeutics AB’s (9IB) Price Rate of Change (ROC) is -2.20, creating a Sell signal.

FAQ

Is 9IB a Buy, Hold, or Sell?
Based on 9IB’s technical indicators, 9IB is a Sell.
    What is 9IB’s RSI (14)?
    9IB’s RSI (14) is 46.06, which suggests 9IB is a Neutral.
      What is 9IB’s MACD?
      9IB’s MACD is -0.06, which suggests 9IB is a Sell.
        What is 9IB’s 5-day moving average?
        9IB’s 5-day moving average is 4.43, which suggests 9IB is a Buy.
          What is 9IB’s 20-day moving average?
          9IB 20-day moving average is 4.48, which suggests 9IB is a Sell.
            What is 9IB’s 50-day moving average?
            9IB’s 50-day moving average is 4.65, which suggests 9IB is a Sell.
              What is 9IB’s 200-day moving average?
              9IB’s 200-day moving average is 4.93, which suggests 9IB is a Sell.
                What is 9IB’s Williams % R (14)?
                9IB’s Williams % R (14) is -51.16, which suggests 9IB is a Buy.
                  What is 9IB’s CCI (14)?
                  9IB’s CCI (14) is -44.73, which suggests 9IB is a Neutral.
                    What is the share price of Infant Bacterial Therapeutics AB?